CancerAid valued at $4.25m after welcoming seed funding from strategic investors - Dynamic Business
Summary
CancerAid has closed a $1.25 million Seed B round and lifted its total valuation to $4.25 million. The Sydney healthtech startup builds an app that helps patients manage their cancer journey and lets clinicians monitor progress remotely. The product already has customers in Australian hospitals and has added its first international customer in Hong Kong. The company plans to expand the platform to other chronic diseases and has released an iPhone version in the Apple App Store.
Funding
Amount
$951.5K
Total raised
Date
August 24, 2016
Announcement date
Investors
Clinton Capital Partners
Lead investors
Company
http://www.osarahealth.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected